Headache Management
Pharmacological Options
- The American College of Physicians recommends NSAIDs (e.g., ibuprofen 400mg) or acetaminophen (1000mg) for short-term relief of tension-type headache 1
- Indomethacin may have advantages due to its ICP-reducing effects in the treatment of headaches 2
- Amitriptyline is recommended for chronic tension-type headache and occipital neuralgia, by inhibiting serotonin and norepinephrine reuptake and blocking sodium channels necessary for neuronal impulse initiation and conduction 1, 3
- Antiepileptic medications (e.g., topiramate) may be considered for headaches, especially if migraine features are present 2
- Opioids should not be prescribed for headaches except for short-term use if multimodal analgesia is ineffective 2, 4
Non-Pharmacological Approaches
- Lifestyle modifications, including regular meals, adequate hydration, sleep hygiene, and stress management, are recommended for headache management 2
- Aerobic exercise or progressive strength training is recommended for headache management, according to the American College of Sports Medicine and the American Academy of Family Physicians 1
Interventional Treatments
- Greater occipital nerve blocks are effective for occipital neuralgia and headaches with an occipital component 2
- Greater occipital nerve blocks may be considered for patients with headaches after spinal anesthesia with narrow-gauge needles 4
- Occipital nerve stimulation (ONS) is recommended for medically refractory occipital neuralgia, with a reported 72.2% pain reduction and 76% of patients achieving at least 50% pain reduction at one year, and a level III recommendation with 70-80% success rates 5, 6
- Botulinum toxin and radiofrequency denervation are options for refractory cases, with 80% and 89.4% good results, respectively 6
Diagnostic Approaches
- Magnetic resonance imaging (MRI) of the cervical spine is essential for diagnosing cervical myelopathy and can help identify underlying causes of occipital neuralgia 5
- Diagnostic nerve blocks can be used to confirm the diagnosis of occipital neuralgia and guide treatment decisions 5
- Diagnostic imaging is not routinely recommended for patients with typical primary headache features and normal neurological examination, but may be considered for atypical headache patterns or neurologic signs, as stated by the American College of Physicians 7
- Red flags that require further evaluation include abnormal neurological examination findings, papilledema or optic disc changes, worsening pattern of headache frequency or severity, headache that awakens patient from sleep, abrupt onset of severe headache, and marked change in headache pattern, as noted by the American Academy of Neurology 7
Device Selection and Safety
- The selection of devices for peripheral nerve stimulation should be based on FDA approval for the specific indication, with considerations for complications such as lead migration, which ranges from 13.9% to 24% in studies 5
- Wireless peripheral nerve stimulation systems have received FDA approval for pain in trunk and extremities, with one device recently receiving expanded indication for headache and axial neck pain 6
- A successful trial with documented ≥50% pain reduction for at least 3 days is required before permanent implantation of peripheral nerve stimulation devices 5
Medication Use and Safety
- Patients should be warned about the risk of medication overuse headache (use of simple analgesics >15 days/month or opioids/triptans >10 days/month) 2
- Common diagnostic errors include confusing occipital neuralgia with migraine and failing to recognize cervical tension as a cause of occipital headache 6
- Associated symptoms such as photophobia, phonophobia, and nausea are suggestive of migraine, according to Nature Reviews Neurology 8
- Cranial autonomic symptoms can be present in primary headaches, as noted by the American College of Radiology 9